India's Surrogacy Shift: Insurance Boom Reveals Critical Safety Gaps

NEW DELHI – March 25, 2026 – A dramatic 50% surge in demand for surrogate insurance in 2025 is signaling a profound transformation within India's reproductive care landscape. This spike, reported by leading specialist SafeTree Insurance, follows the nationwide implementation of the Surrogacy (Regulation) Act, which has fundamentally reshaped the industry from an unregulated commercial market to a tightly controlled, altruistic framework. But as clinics and intending parents rush to comply with new legal mandates, a critical and dangerous gap has emerged: the insurance designed to protect surrogate mothers may be woefully inadequate, leaving the most vulnerable participants exposed to catastrophic financial and medical risks.

The Dawn of a Regulated Era

Once known as a global hub for commercial surrogacy, with an industry estimated at over 25,000 births annually around 2012, India has pivoted sharply towards ethical governance. The Surrogacy (Regulation) Act, which came into full effect in early 2022, banned commercial surrogacy and established a framework for altruistic arrangements, where a surrogate must be a close relative and receives no monetary compensation beyond medical expenses and insurance.

A cornerstone of this new legislation is the mandatory provision of insurance for the surrogate mother. The law requires intending parents to secure a 36-month health and life insurance policy for the surrogate, covering the entire pregnancy and postpartum period. This was designed to be a key safeguard, ensuring surrogate mothers are protected from the significant medical risks associated with pregnancy, without incurring personal financial burdens.

This regulatory shift has catalyzed the formalization of the sector. Companies like SafeTree, which has already insured over 1,800 surrogate mothers across 17 states, are at the forefront of this change. The rising demand for their specialized products reflects a broader industry move towards structured compliance and accountability.

A Dangerous Discrepancy: The True Cost of Care

Despite the new legal framework, a critical oversight is leaving surrogate mothers dangerously exposed. The Act mandates insurance but fails to specify a minimum coverage amount, leaving the decision to market forces and the discretion of clinics and parents. Industry observations indicate that most standard policies being purchased range between a mere ₹2–5 lakh.

Medical experts warn this amount is grossly insufficient. Surrogate pregnancies can carry heightened risks, including preeclampsia, gestational diabetes, and postpartum hemorrhage. In severe cases, complications can lead to multi-organ failure requiring prolonged stays in an Intensive Care Unit (ICU), where costs can quickly spiral out of control.

According to Vikas Anand, CEO of SafeTree Insurance, rising medical inflation has exacerbated the issue. He cited a recent, harrowing case where a surrogate mother developed acute liver failure with multi-organ complications. Her treatment required extensive ICU care, resulting in hospitalization costs exceeding ₹14 lakh—nearly three times the maximum coverage of many standard policies. Without adequate insurance, such a situation could have resulted in financial ruin for the family or a tragic compromise in care.

This stark reality has led experts to call for a much higher standard. Leading clinicians and industry specialists now recommend a minimum insurance coverage of at least ₹10 lakh to create a genuine safety net. "Surrogate pregnancies can sometimes involve complex and unpredictable medical conditions requiring advanced care," stated Dr. Vipin Chandra, Chief of Clinical & Lab Operations at Indira IVF. "Ensuring adequate and compliant insurance coverage is not optional; it is fundamental to ethical and responsible surrogacy practice."

Insurance as the New Bedrock of Compliance

The transition from an industry driven by scale to one defined by scrutiny has repositioned the role of insurance. It is no longer a secondary consideration but a foundational element of ethical practice. "In this new environment, insurance is no longer a support function; it's the foundation of ethical practice," Vikas Anand emphasized, highlighting the shift in mindset across the ecosystem.

This new reality has forced clinics and intending parents to navigate a complex insurance market. Both the Insurance Regulatory and Development Authority of India (IRDAI) and the National ART Board have issued guidance urging the use of surrogacy-specific policies. Generic health plans often contain exclusions or limitations that fail to cover the unique risks associated with a surrogate pregnancy, creating a false sense of security and a high risk of claim rejection.

Specialized providers are working to fill this need by coordinating with fertility clinics, legal experts, and approved insurers to create compliant products that address real-world medical cost exposure. The goal is to ensure that the policies not only meet the letter of the law but also its spirit—to provide comprehensive protection for the surrogate mother.

Navigating the Path to Ethical Leadership

The 50% rise in insurance demand is more than a business statistic; it reflects a systemic shift towards financial preparedness and ethical accountability in India's surrogacy journey. The country is moving away from its controversial past and attempting to build a new reputation as a potential leader in responsible reproductive care. However, this ambition hinges on closing the gaps that still exist in the protective framework.

The welfare of the surrogate mother must remain the central focus. While the law aims to prevent financial coercion through its altruistic model, failing to protect a surrogate from crippling medical debt would represent a different but equally severe form of exploitation. The current discrepancy in insurance coverage is a critical vulnerability in an otherwise well-intentioned regulatory structure.

As the industry matures under the new laws, the conversation is shifting from mere compliance to the quality of that compliance. The path forward requires a multi-stakeholder effort—from regulators setting clear minimum coverage standards to clinics educating parents on the importance of robust protection. As India navigates this new chapter, ensuring that the financial safety net is as strong as the legal framework will be the ultimate test of its commitment to truly ethical surrogacy.